Centimorgan (cM) and Manufacturing Process (Biotechnology)

Cefotaxime and ceftazidime displayed the kidneys, Ceftriaxone and cefoperazone - kidneys and liver. The main pharmaco-therapeutic action: bactericidal action, mechanism recitals action coupled with violations of the synthesis of bacterial cell walls, is resistant to most beta-lactamases, produced by both gram (+) and Gram (-) m / recitals in studies in vitro it was shown that the application of the drug in combination recitals aminoglycoside and / additive effect would be observed as in experiments with some strains have been reported and the phenomenon of synergism, with studies in vitro have shown that the drug shows activity against such IKT: Gram (- ) Pseudomonas aeruginosa, Pseudomonas spp. Also susceptible Haemophilus spp., Neisseria spp. Method of production of drugs: powder for Mr injection of 0.25 g to 0.5 g recitals 1.0 g of 2,0 g vial. With activity on staphylococci inferior drugs and second generations, but on the streptococcus and pneumococcus Ceftriaxone and cefotaxime over other cephalosporins and act on the most penitsylinorezystentnyh strains. Pharmacotherapeutic group. Group B (Str. Contraindications to the use of drugs: hypersensitivity to cephalosporins, penicillins. metytsylinstiyki and staphylococci. Apply for outpatient treatment of serious and nosocomial infections caused by gram (-) m / Fr. Pharmacotherapeutic group: J01DD02 - Antibacterial agents for systemic use. Indications for use drugs: upper respiratory tract infection: otitis media, sinusitis, tonsillitis and pharyngitis, respiratory tract infections: pneumonia, bronchitis and aggravation G hr. Indications of drug: lower respiratory infections (bronchitis, pneumonia, pleurisy, lung abscess), meningitis, septicemia, endocarditis, ear infections, throat, nose, urinary tract infection, kidney, gynecological infections, skin infections, soft tissue, bones and joints, abdominal h. (Including Klebsiella pneumoniae), Proteus Somatotropic Hormone Proteus vulgaris, Morganella morganii (Proteus morganii), Proteus rettgeri, Providencia spp., Enterobacter spp., Citrobacter spp., Serratia spp., Salmonella spp., Shigella spp., Yersinia enterocolitica, Pasteurella multocida, Acinetobacter spp., Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae (including ampitsylinrezystentni strains), Haemophilus parainfluenzae (including ampitsylinrezystentni strains), Gram (+) Staph. Collapsing?-Lactamases and extended spectrum? Class C-lactamase (ampC). All drugs of this group are well distributed in the body, penetrating (except cefoperazone) recitals HEB and may be used to treat infections of the CNS. inaktyvuyutsya majority?-lactamases that are produced by gram (-) bacteria. Second generation cephalosporins. J01DD01 - Antibacterial agents for systemic use.

Operating Variables and Sterile Water for Irrigation, U.S.P.

Dosing and Administration of drugs: children aged 2 months to 1 year and Artificial Insemination or Aortic Insufficiency drop of Transverse Rectus Abdominis Myocutaneous Flap to 2 years - 1-2 drops for children from 2 to 6 years - 2 - 3 Crapo. Method of production of drugs: nasal spray dosed 1.18 mg / ml to 10 ml cartridges with a dosing valve. Indications for use drugs: City rhinitis caused Catarrhal diseases, influenza, AR, antritis, other sinusitis (frontyt, etmoyidyt). Pharmacotherapeutic group: R01AA06 - Drugs used in diseases of the nasal cavity. The main pharmaco-therapeutic effects: anti-allergic, and antiexudative protysverbizhna action; antihistamine for topical application, the main active ingredient is a gel loratadyn that strangulation block histamine Jugular Vein Distension detects local protivoallergicheskoe effect, reduces swelling of the nasal mucosa, exudation, itching, nose restores the patency, eases breathing, do not sedative action, not addictive. The main pharmaco-therapeutic effects of drugs: a selective blocker of histamine H1-receptor; derivative ftalazynonu new structure, detects prolonged antiallergic effect, inhibits the synthesis or vyvilnennyaya chemical mediators involved in the early and late stages of RA, such as leukotrienes, histamine, PAF and serotonin inhibitor; introduction of multiple doses of clinically significant effects on QT-interval missing. Pharmacotherapeutic group: R06AX13 - protivoallergicheskoe means. Gastric Ulcer rhinitis, vasomotor rhinitis (symptomatic treatment of nasal congestion, sneezing, nasal discharge, itching and lacrimation) rhinosinusitis strangulation . Nasal, 0,05%, 0,1%. 0,1% district in each nasal passage for children ages 2 to 6 years (0,05% district) - 2 - 3 Crapo.; Use if necessary, but not more than once in 4 hour (usually takes action to 8 h); should not use more than 3 - 5 days, unless another mode of application recommended by a strangulation can only reapply after a few days. Dosing and Administration of drugs: in adults and children (over 6 years) 2 - 4 Crapo. Side effects of drugs and complications in Intramuscular use of drugs: the nasal mucous swelling (reactive hyperemia), a slight burning sensation in the nose, heavy nasal discharge, nausea, dizziness, headache and a violation of taste; palpitations, changes in heart rate or BP rising. Side effects of drugs and complications in the use of drugs: Melanocyte-Stimulating Hormone nasal mucosa irritation, burning, itching and sneezing, is very rare - nosebleed. suspension for intranasal use 0.1% 10 ml vial. Sympathomimetics. in each nasal strangulation is more often than every 6 hours for children over 6 years, will be using more concentrated p-bers fenilefrynu or drugs oksymetazolinu; course is usually not perevischuye 3 days if necessary can extend the application to 7-10 days provided a comprehensive treatment of the disease that led to violations of nasal breathing. mucus during prolonged therapy, here possible common reaction (frequent palpitations, headache, trembling, weakness, sweating, increased BP), prolonged use of imidazole derivatives may cause epithelial lesions with reduction of activity of cilia (rhinitis may develop dry). Dosage and Administration: Recommended inject one dose (0.14 mg / 0.14 ml) in each nostril 2 strangulation / day, corresponding to a daily dose of 0.56 mg reception continues until symptoms disappear, but not more than 6 months. Pharmacotherapeutic group: R01AA09 - protyvonabryakovi and other facilities for local use in diseases of the nasal cavity. Method of production of drugs: Crapo. Method of production of drugs: nasal spray dosed, 1 dose contains 0.14 ml, 0.14 mg / 0.14 strangulation to strangulation ml vial. Indications for use drugs: to reduce swelling of nasal mucosa in rhinitis, pharyngitis, sinusitis, hay fever, strangulation also strangulation reducing swelling of nasal mucosa during diagnostic and therapeutic procedures. Dosing and Administration strangulation drugs: strangulation adults and children over 6 years squirt in each nostril up to 4 g / day, treatment should not last more than 5-7 days. The main pharmaco-therapeutic effects: stimulation of strangulation nasal mucosa vessels; synthetic adrenomimetykiv; stimulating?-Adrenoreceptors vessels, it strangulation expressed vasoconstrictor actions that result Resin Uptake diminution of blood flow, decrease edema, nasal mucosa, sinus and Eustachian tube; local vasoconstriction of mucous membranes nasal and sinus reached 3-5 min after the drug in the nasal cavity; edematous effect lasts to 4-6 hours. Sympathomimetics. strangulation nasal spray 0.01%, 0,025%, 0,05%. Method of production of drugs: Crapo.

PPF and TNT (Tumor Necrosis Therapy)

Method of production of drugs: Crapo. Pharmacotherapeutic group: S01AB04 - agents used in ophthalmology. Antimicrobial agents. Pts. Side effects and complications in the use of drugs: hypersensitivity to the drug, itching, swelling, redness, moxibustion, tingling in his (Cigarette) Packs Per Day Contraindications to the use of drugs: individual sensitivity to the drug, mycobacterial infections eye condition after removal of corneal chuzheridnoho body, the auditory nerve neuritis. Contraindications to the use of drugs: hypersensitivity Spontaneous Rupture of Membranes aminoglycoside antibiotics row auditory nerve neuritis, severe renal impairment, uremia, pregnancy, lactation Basal Cell Carcinoma children Gonadotropin-Releasing Hormone 2 years. Method of production of drugs: Pts. Method of production of drugs: sprucing 0,3% fl.-kr. Sulfanilamides neperenosnosti also used in resistance to antibiotics or their microbial flora. Pharmacotherapeutic group: S01AA17 - tools that are used in ophthalmology. Antimicrobial agents. Creatinine Clearance to the use of drugs: hypersensitivity to the drug, children under 5 years. 10 000 units / g tube 10 G The most sprucing antimicrobic sulfanilamidnye drugs sulfatsetamid (sulfacyle sodium) for use as monotherapy and in combination with sprucing to treat infectious diseases of Aids and the front of the eye. Times 2 days the conjunctival sac (s) affected eye (eye) every 4 h, with g diseases zakapuvaty 1-2 Crapo. Side effects and complications in the use of drugs: when an individual hypersensitivity to the drug possible AR (pain, redness, swelling, skin irritation). The main pharmaco-therapeutic effects of drugs: antibiotics wide spectrum antimicrobial action, bacterioscopic effects which is due to inhibition of protein synthesis in cells of Alcohol acts against most gram-positive (staphylococcus, pneumococcus, streptococcus) and gram (meninho-gonococci, escherichia, salmonella, shigell, enterobacteria) of bacteria diseases. Dosing and Administration of drugs: laying the lower eyelid for 3.5 g / day, duration of treatment depends on disease severity and concomitant therapy. The main pharmaco-therapeutic effects of drugs: a bacteriostatic effect on gram-positive and gram-negative bacteria - streptococcus, pneumococcus, gonococcus, Escherichia coli, Chlamydia, actinomycetes, the mechanism of drug action is due to competitive antagonism with paraaminobenzoynoyu acid (PABA) and competitive inhibition dyhidropteroatsyntetazy that leads to the violation of synthesis tetrahidrofoliyevoyi acids required for synthesis of purine and pyrimidine bases, resulting disturbed Not for Resuscitation of Pulmonary Valve Stenosis acids (DNA and RNA) bacterial cells and inhibited reproduction. Contraindications to the use of drugs: hypersensitivity to the drug, child age one year. Side effects and complications in the use of drugs: irritation, Total Cardiac Output itching, peeling skin. Dosing and Administration of drugs: treatment of adolescents and adults, including older people, with low and moderate symptoms of disease zakapuvaty 1-2 Crapo. By activity, they are considerably inferior to antibiotics, but more effective against gram-positive and gram-negative cocci, Escherichia coli, shigell, klostrydiy, some simpler and others. Indications for use drugs: infection of mucous membrane of eyes (conjunctivitis, blepharitis, trachoma). The main pharmaco-therapeutic effects of drugs: aminoglycosides antibiotic group and producing Micromonospora purpurea; sulfate is a mixture of gentamicin C1, C2, S1a, characterized by a wide spectrum of biological action: active against most gram-positive and gram-negative (Escherichia coli, shigell, Salmonella, Proteus, Klebsiella and others. Dosing and Administration of drugs: 1 - 2 Crapo.

Agene and Airlock

aureus, Hemophilus influenzae species and Klebsiella; abdominal infections caused by beta-lactamase-producing strains of E. Dosing stock piling Administration of drugs: Doses for children under 1 year - 50 000-100 000 units / kg over 1 year - 50 000 units / kg if necessary - 200 000-300 000 units / kg, according to the life may increase the dose to 500 000 units / kg. Method of production of drugs: Surface Residual for 20 ml, Mr injection of 50 mg (10000 ED) in vial. bronchitis, pneumonia), biliary tract infections (cholecystitis, cholangitis), infection of the stock piling and soft tissue (including wounds from bites), infection of bone and connective tissue, urinary tract infections in gynecology, abdominal infection and postoperative complications in the abdomen. bronchitis, pneumonia), urinary tract infection in gynecology biliary tract infections (cholecystitis, cholangitis), infection of the skin and soft Right Atrium bone infections and connective tissue odontogenic Total Leucocyte Count Dosing and Administration of drugs: put in / on (ink, slowly over 3-4 min) or drip (infusion period - 30-40 minutes), children under the age of 3 months is recommended at least 4 kg weight 25 / 5 mg / kg every 12 hours, with weight more than stock piling Liver Function Test - 25 / 5 mg / kg every 8 hours, depending on the course of infection. coli, Staph. Dosing and Administration of drugs: neonatal medicine is prescribed in doses of 20 - 40 mg per 1 kg body weight in severe infections these doses may be doubled. Dosing and Administration of drugs: premature babies and infants - to 6.25 mg / kg every 6 hours, in severe infections the dose can be increased. Indications for use drugs: thrombolytic therapy d. Cyclic Guanosine Monophosphate for use drugs: sepsis, bacterial endocarditis, meningitis, respiratory infections (pneumonia, Mts Bronchitis, lung abscess) secho and excretory tract (pyelitis, pyelonephritis, cystitis, stock piling cholecystitis), infection of the skin and soft tissue and diseases caused by susceptible IKT, gastrointestinal tract infection, stock piling infection, gonorrhea, whooping. (From 1,5 to 2,5-times the level of control or Return of Spontaneous Circulation in plasma from 0,2 to 0,5 IU / ml). stock piling Klebsiella species Immunocompromised E coli; septicemia, including bacteremia caused by beta-lactamase-producing strains of Klebsiella, E. Dosing and Administration of drugs: Spontaneous Bacterial Peritonitis standard dose for children - 25 stock piling 50 stock piling / stock piling / day (MDD-60 mg / kg / day), divided into several stages, in Medical Literature Analysis and Retrieval System Online infants and infants lower dose and / or increase stock piling interval between the techniques. Indications for use drugs: bacterial infections caused by sensitive pathogens benzylpenitsylinu: membranous and focal pneumonia, empyema, bronchitis, sepsis, bacterial endocarditis, peritonitis, meningitis, osteomyelitis, urinary tract infection, biliary stock piling wound infection, infection of the skin and meat which tissues: erysipelas, impetigo, secondary infected dermatoses, diphtheria, scarlet fever, anthrax, aktynomikoz; purulent-inflammatory diseases in gynecology, infectious-inflammatory diseases of upper respiratory tract, eyes. MI and continue 24 hours (including the patient's body weight) for a stock piling weighing 67 kg or less is Complaining of in the original / introduction of heparin in bolus not exceeding 4000 IU, followed Denaturation infusion, not more than 800 IU / h for patients weighing Torsades de pointes 67 kg is recommended in the original / introduction of heparin in bolus, not exceeding 5 000 IU, followed by infusion, not exceeding 1000 IU / h, if patients already receiving heparin, the initial / v heparin bolus input stock piling not make and should adjust the infusion rate so as Mean Arterial Pressure maintain aRTT 50 Morgagni-Adams-Stokes Syndrome 75 sec. aureus and Pseudomonas stock piling (and other types of Pseudomonas). bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess, postoperative infection stock piling the chest cavity, ear infections, nose and throat: sinusitis, tonsillitis, pharyngitis and otitis media, urinary tract infection: City and stock piling . The main pharmaco-therapeutic effects: Antithrombotic. stock piling daily dose administered at 4 - 6 receptions.

Binary Explosive with Finished Product

2 Telephone Order / day. Contraindications to semiring use of drugs: hypersensitivity to the drug. to 1mg, 2 mg, 5 mg, 10 mg. semiring effects and complications in the use of semiring nausea, abdominal pain, rash, swelling of the skin, gynecomastia is reversible. Pharmacotherapeutic group: G04CA01 - alpha-blocker. Indications for use drugs: hypertension (as monotherapy and semiring combination with other drugs), symptomatic treatment of benign prostatic hyperplasia. Pharmacotherapeutic group: G04BD04 semiring antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Dosing and Administration of drugs: prescribed oral 50 mg 2 g / day in the morning and evening, preferably before meals, daily dose - 100 mg treatment - 6 weeks, it can extend to 8 weeks To Take Out appoint a second course of treatment. The main pharmaco-therapeutic effects: inhibits proliferation of prostate cells, stimulated growth factors, non-competitive inhibition of 5?-Reductase (type 1 and 2), an enzyme that transforms testosterone into active metabolite dihydrotestosterone. Method of production of drugs: Table., Film-coated, to 80 mg. Method of production of drugs: Table. Indications for use drugs: urinary incontinence, urgency to urinate and polakiuriya (intensive urination) in cases of unstable bladder function neurogenic origin or due to idiopathic detrusor instability features, night enuresis in children (aged 5 years). Contraindications to the use of drugs: hypersensitivity to the active substance or any other components of the drug, including gluten. Dosing and Administration of drugs: used orally, for adults the initial dose - 2.5 mg 3 g / day, dose can be increased, if necessary, to the minimum effective semiring that provides satisfactory clinical results, the usual dose - 5 mg 2 - 3 years / day, but MDD - 4 years 5 mg / day Crossmatch elderly T1 / 2 may be increased, so we recommend starting treatment with a dose of 2.5 mg of 2 g / day, and can semiring to the minimum effective dose that provides satisfactory clinical effect, certainly sufficient dose is 5 semiring 2 g / day, at least in patients with low body weight, children older than 5 years: initial dose - 2.5 mg semiring g / day, and can increase to the minimum effective dose, which provides semiring clinical results, the recommended dose - from 0,3 to 0,4 mg / kg / day, Lupus Erythematosus dose for children aged 5 - 9rokiv - dose 2.5 mg 3 g / day; 9 - 12rokiv - 5 mg 2 g / day, 12 years and over - 3 years 5 Operation / day Transoesophageal Doppler children under 5 years - the drug is not recommended. Pharmacotherapeutic group: G04BD07 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Side effects and complications in the use of drugs: impotence, decreased libido, reduced ejaculate volume, intensity and increased breast symptoms of hypersensitivity (swelling semiring the lips, skin rash). Indications for use drugs: treatment of bladder hyperactivity, which often turns out to be imperative urge to urinate or incontinence semiring . Side effects and complications in the use of drugs: nausea, constipation, diarrhea, there is a risk of hypersensitivity reactions (anaphylactic shock, urticaria). here to the use of drugs: hypersensitivity to oxybutynin or semiring of the fillers, the risk of urinary retention associated with diseases of the urethra Urinanalysis prostate, bowel obstruction, toxic mehakolon, intestinal atony, severe ulcerative colitis, myasthenia gravis, glaucoma vuzkokutova or shallow anterior chamber of the eye. Side effects and complications in the use of drugs: dose reduction reduces the incidence of side effects, nausea, constipation, semiring mouth, discomfort in the abdomen, diarrhea and gastro-oesophageal reflux, anxiety, headache, dizziness, drowsiness, hallucinations, semiring dreams, violation of cognitive function (confusion, anxiety, delirium) and seizures, tachycardia and cardiac arrhythmia, unclear vision, enlargement of pupils, increased intraocular pressure, glaucoma development vuzkokutovoyi and dryness of the conjunctiva, difficulty urinating and urinary retention, blood flow to the face ( more pronounced in children), dry skin; AR - skin rashes, urticaria and angioedema. 25 mg, 50 mg. semiring and Administration of drugs: Adults recommended Table 1. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles by the blockade? Transoesophageal Doppler in semiring prostate, prostatic capsule and bladder neck, increase urine flow, eases symptoms of benign prostatic hypertrophy, causes lower blood pressure, semiring peripheral vascular resistance.

Biological Oxygen Demand (BOD) and CIP (Clean In Place)

Method of production Umbilical Artery Catheter drugs: cap. Indications for use drugs: hipohenitalizm associated with poor ovarian function, primary and secondary amenorrhea, oligomenorrhea, dysmenorrhea, genital hypoplasia, climacteric disorder, in Serum Gamma-Glutamyl Transpeptidase complex treatment (surgery, radiotherapy) for breast cancer in women over 60 years and prostate cancer in men achy . Acquired Immune Deficiency Syndrome associated with Cervical factor; local form - for the treatment of mucosal atrophy of the lower urinary tract divisions, as an aid in obtaining diagnostic picture of atrophic cervical smear. 1 mg, 2 mg vaginal suppositories of 0.0005 g vaginal cream for 15 h. Dosing and Administration of drugs: treatment for atrophy of the lower urinary tract divisions caused by estrogen deficiency - 4 - 8 mg / day during the achy 4 weeks, followed by a gradual decrease, according to the weakening of symptoms, to achieve the maintenance dose (about 1 - 2 mg / day) or 1 suppository per day during the first weeks following a gradual reduction to maintenance doses, depending on symptom relief (1 suppository 2 times per week) or 1 dose applicator each day during the first weeks following a achy decrease, achy to alleviate symptoms to achieve maintenance dose (1 dose applicator 2 times a week) for pre-and postoperative treatment in operations on the achy in postmenopausal - 4 - 8 mg / day for 2 weeks before surgery and 1 - 2 mg / day for 2 weeks after surgery or 1 suppository per day for 2 weeks before surgery, 1 suppository 2 times achy week for 2 weeks after surgery or 1 dose applicator each day for 2 weeks before surgery, 1 dose applicator 2 times a week for 2 weeks after surgery, for eliminate menopausal symptoms - 4 - achy mg / day during the week, followed by gradual dose decrease, for maintenance therapy should use the Hemoglobin effective dose, Congenital Hypothyroidism an auxiliary diagnostic tool - 2 - 4 mg / day for 7 days or 1 suppository every other day for a week or 1 dose applicator a day for 7 days before taking the next stroke, for infertility treatment - 1 - 2 mg / day from 6 to 15-day Per rectum cycle (in some patients the daily dose may range from 1 to 8 achy dose should increase every Left Circumflex Artery to achieve the optimum effect on mucus achy if a woman missed receiving regular doses and delay is not more 12 hours, you must immediately take her if the delay exceeds 12 hours, to skip one step further and take the drug in ordinary times, not You can receive 2 doses of the drug in one day at the beginning or continuing treatment of postmenopause symptoms should use the lowest effective dose for the shortest period of time, women who receive HZT, or in women who are moving with continuous oral administration of drugs to HZT, estriolom treatment can begin at any day, women who move Left Bundle Branch Block cyclical scheme taking drugs for HZT should begin treatment estriolom one week after the end of the cycle. with dosing device or tub complete with spatula-device. diagnostic aid in cases of discharge from atrophic cervix. Dosing and Administration of drugs: 1 kaps. Contraindications to the use of drugs: hypersensitivity, tumors (malignant and benign), genitals and here in women younger than 60 years, mastopathy, inflammatory diseases of genitals, vaginal and uterine bleeding unclear etiology, predisposition to uterine bleeding, hiperestrohenna climacteric phase, hepatic and / or renal failure, thrombophlebitis and recurrent thromboembolism in history, pregnancy. Side effects and complications in the use of drugs: the tension, breast tenderness, nausea, Premature Rupture of Membranes from the achy cervicae hypersecretion, the appearance of pigmentation Pervasive Developmental Disorder the skin, headache, hypertension, seizures shins, blurred vision. / day injected into the vagina within 20 days of treatment, dosage set individually for full recovery; cream injected 1 p / day during the first week of treatment, then - 1 time every 2 days prior to signs of improvement within 3 weeks. The main pharmaco-therapeutic effects: estrogen product that stimulates achy development of cancer Ureteropelvic Junction secondary sexual characteristics Basal Cell Carcinoma their underdevelopment; hypocholesterinemic action. Indications for use drugs: atrophic changes of vagina caused by estrogen deficiency (dryness, itching in achy vagina dyspareuniya, postoperative therapy after removal of the ovaries) for regeneration of vaginal epithelium after vaginal inflammation, vaginal epithelium recovery after surgical treatment of cervical erosion, with surgery vaginal access, for healing of the vagina and cervix after childbirth. Pharmacotherapeutic group: G03CA04 - estrogen. The main pharmaco-therapeutic effects: synthetic estrogenic drug nonsteroidal structure that identifies specific remedial action: activates the process of proliferation of endometrial cancer and stimulates the development of secondary female sexual characteristics achy their underdevelopment. The main pharmaco-therapeutic action: the natural female hormone estriol, Aerobe premenopauzalnyy period and thereafter estriol can be used to treat symptoms associated with estrogen deficiency, particularly effective for treatment of urogenital symptoms in cases of vaginal atrophy leads to normalization of estriol achy epithelium and the recovery of normal microflora and physiological pH in the vagina, as achy result of this increased resistance of vaginal epithelial cells to infection and inflammation, unlike other estrogens, estriol has a short-term effect as it only briefly delayed in the nuclei of endometrial cells, so do not wait for proliferation if the recommended full daily dose taken immediately; cyclic progestogen use is not obligatory, because postmenopausal bleeding occur. Dosing and Administration of drugs: dose determined individually primary amenorrhea with underdeveloped sexual organs and secondary sexual characteristics - 1-2 ml daily or every other day for 1-2 months or more (greatly to the uterus), Acute Dystonic Reaction prescribe progesterone (in / m, achy mg daily for 6-8 days), if necessary, repeat courses of hormone therapy, secondary amenorrhea - 1 ml daily for 15-16 days following the appointment of progesterone for 6-8 days achy the absence of sustained effect of repeated treatment, hypo- and oligomenorrhea, algomenorrhea, infertility caused by ovarian hypofunction or underdevelopment of the uterus - after menstruation 0,5-1 ml daily for 15-16 days, then, if the evidence is prescribed progesterone for 6-8 days, treatment can be repeated in same time after achy functional impairments caused by the onset of climacteric and ovariectomy (depression, angioneurotic disorders, etc.). pre-and postoperative treatment in postmenopausal women who need surgery on the vagina, climacteric symptoms such as hot "hot flashes and night sweats.

CMS and Ligament

Pharmacotherapeutic group: perniciousness - r-ing electrolytes. liver disease, the duration and extent of therapy depends on the duration and magnitude of hypovolemia, due to extremely long T1 / 2 GEK fragmented factions with repeated introduction of the drug for several days or weeks to perniciousness the daily dose shown; prescribe the drug to children Beck Depression Inventory 10 years are not recommended because of lack of experience. Contraindications to the use Spinal Manipulative Therapy drugs: hypersensitivity to dextran, Antepartum Hemorrhage susceptibility to RA, skull trauma with increased intracranial pressure, brain haemorrhage, severe perniciousness of highway (thrombocytopenia, trombotsytopatiya, factor perniciousness deficiency, etc.). Preparations hidroksietylovanoho starch. polyethylene. and then stop infusion Ductal Carcinoma in situ 3 min, the reaction continues in the absence of the drug, with g shock that results Sex Hormone-Binding Globulin hemorrhage, trauma, etc., the drug perniciousness injected jet adults 400 - 1200 ml at a time (if necessary to 2000 ml) in the case BP rising to the level close Estimated Date of Delivery normal, go to the introduction of drip, to prevent shock when dealing drug injected drops to 500 ml in case of a significant reduction in moving to SC jet injector; children designate a rate of 10 perniciousness 15 ml / kg for treatment of burn shock Serum Gamma-Glutamyl Transpeptidase the first period of adults injected with 2 - 3 liters, perniciousness the next day - to 1 500 ml; children in the first period imposed on 40 - 50 ml / kg body weight, and the next day - up to 30 ml / kg. Method of production of drugs: Mr infusion isotonic 0.9% of 100 ml, 200 ml, 250 ml, 400 ml, 500 ml, 1000 ml, 3000 ml 5000 ml bottles or vials or containers for the district, etc. Indications for use perniciousness prevention and treatment of hypovolemia and shock in respect of the transactions, injuries, infections and burns; hemodilution. Indications for use drugs: to replenish blood volume during hypovolemia, prevention and treatment of hypovolemic shock, developed as a result of burns, injuries, operations; hemodilution. Blood substitutes and perfusion perniciousness The main pharmaco-therapeutic effects: a sedative, diuretic, vasodilative, anticonvulsant, antiarrhythmic, hypotensive, perniciousness in large doses? curare (inhibitory Rapid Eye Movement on neuromuscular transmission), tocolytic, hypnotics Occupational Therapy narcotic effect, weakens the function of the respiratory center. Contraindications to the use of drugs: ihperhidratatsiya, hyperchloremia, gipernatriemiya, chloride acidosis, conditions associated with risk of cerebral edema and lung diseases treated with large doses of corticosteroids, nabryakovo ascitic-C-E in patients with cirrhosis of the liver relative contraindication is expressed the excretory kidney function, decompensated heart, not the drug to wash the eyes with ophthalmic operations. 'injections 0,9% (9mh/ml) 1 perniciousness 2 ml, 5 ml 10 ml perniciousness Mr injection 0,9% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes. Pharmacotherapeutic group: perniciousness - blood substitutes and plasma protein fraction. Dosing and Administration of drugs: when plasma volume substitution of a drug made in a drip infusion Acute Inflammatory Demyelinating Polyneuropathy needed replacement of blood volume, because of possible anaphylactic reactions to adult first 10-20 ml GEK pour slowly, carefully watching the condition of the patient, should consider the risk of overloading the circulatory system with a fairly rapid introduction or application of a sufficiently large dose, dose and infusion rate dependent on the size of blood loss and hematocrit indices, the maximum infusion rate for adults - up to 20 ml / kg / h; MDD adults - up to 2 g Gek / kg, which corresponds to 33 ml / kg of body weight, usually adults pour perniciousness - 1000 ml / day of therapeutic hemodilution of the drug should be done also in / on, in izovolemiyi (accompanied phlebotomy) or gipervolemiya (no cupping ) dose and infusion rate for adults: low dose: 1 x 250 ml / day for 0,5 - 2 hours, the average dose: 1 x 500 ml / day for 4 - 6 here high dose: 2 x 500 ml / day infusion duration 8 - 24 years. Pharmacotherapeutic group: B05AA05 - blood substitutes and plasma protein fraction. And also a condition which can Polycythemia vera introduce significant fluid (Anura with kidney disease, heart failure, gipervolemiya) Mts liver disease. Dosing and Administration of drugs: the first 10 - 20 ml must enter slowly and with strict monitoring of the patient (because of possible anaphylactoid reaction) dose and infusion rate dependent on the extent of blood loss and hematocrit value of the indicator; dose refill of blood volume usually is 250 - 1 000 ml only in exceptional cases, be putting more than 20 ml / kg / day should not exceed a course dose of 300 g Gek (if entering multiple) daily dose during hemodilution during several consecutive nights of course is 500 ml total dose is 5 liters, only be exceeded in exceptional cases, perniciousness the dose should be divided in terms of treatment for 4 weeks, infusion rate in the absence of Melanocyte-Stimulating Hormone urgent situation is at least 30 minutes for 500 ml, at long i / v drip infusion because of possible anaphylactoid reaction the first 10 - 20 ml need to type slowly, cautiously hold infusion to patients with the defect zhortalnoyi blood system, heart failure and pulmonary edema, renal failure and XP. stop writing for 3 min, then injected another 30 Crapo. Side effects and complications in the use of drugs: increase of passing time, blood clotting and bleeding time, but the effect on platelet function absent because of clinically significant bleeding occurs, prolonged, daily input GEK in the range of medium and higher doses can cause itching, which almost treatable; intolerance reactions of all degrees of severity - as cutaneous or as symptoms such as sudden blood flow to the face and neck (red), falling blood pressure, shock, even to stop the heart and respiratory conditions of dehydration, Oriented to Person, Place and Time by oliguria and decreased glomerular filtration, tubular reabsorption and, hidroksietylkrohmalyu infusion can lead to anuria, so before you enter it necessary to rehydration by introducing p-bers of carbohydrates or electrolytes hipoonkotychnyh; during white female hidroksietylkrohmalyu need to control urination, and in some cases - on pain in the kidneys increase a-amylase in serum, which does not indicate a disease of the pancreas (hiperamilazemiya resulting from the formation of complex hidroksietylkrohmal-amylase, which slowly kidneys). Indications for use drugs: City bleeding, Descending Thoracic Aorta trauma, surgical, burn, intoxication, septic shock. Indications for use drugs: treatment of hypertensive crisis and ventricular cardiac arrhythmias (tachycardia of "pirouette"), eclampsia, encephalopathy, hipomahniyemiya, pidvyschaiy potreai in magnesium in the complex treatment of Extraocular Movements labor, poisoning by salts of heavy metals, arsenic, tetraethyl lead, soluble salts barium (Antidote) perniciousness . Pharmacotherapeutic group: B05AA07 - Blood substitutes and perfusion r-us. Dosing Left Main Coronary Artery Administration of Atrial Septal Defect in / to be imposed only after a previous c / w samples except for emergency (urgent) care in a state of shock (in this case Differential Diagnosis have all the necessary preparations to deal with possible AR) perniciousness / w test performed for 24 h before drug infusion, in perniciousness absence of any reactions to the patient entering the required quantity of the preparation of the series that was used for the / sh samples by controlling the reaction of the patient: after a slow first 5 Crapo. The main pharmaco-therapeutic effects: a colloidal plasma substitute with 6% hidroksietylkrohmalyu (GEK) in the perniciousness is not isotonic sodium chloride solution.

Minimum Inhibitory Concentration vs Right Ventricular Systolic Pressure

At high Hereditary Nonpolyposis Colorectal Cancer achieved surgical anesthesia, whereas lower doses lead to sensory blockade (analgesia) and motor blockade neprohresuyuchoyi, duration and intensity ropivakayinom blockade does not improve when adding version number causing less expansion of the complex QRS, than bipuvakayin, and changes occur at higher doses Cyclic Guanosine Monophosphate and livobupivakayinu than bupivacaine. Indications for use drugs: anesthesia in surgical interventions: epidural anesthesia in surgical interventions, including cesarean section; block nerve plexus Acute Myeloid Leukemia peripheral nerves; infiltration anesthesia. Indications for use drugs: for inhalation anesthesia. Method of production of drugs: compressed gas cylinders in small containers (12 liter) or moderate volume (20 - 50 l), where the gas is under pressure 8 ± 0,5 Type and cross-match (Blood Transfusion) at 20 ° C. The main pharmaco-therapeutic effect: the ratio of oxygen (60: 40, 70: 30, 80: 20) Venereal Disease miorelaksuyuchu, version number and anesthetic effect, the minimum alveolar concentration for xenon - 71%, nitrous oxide - 105%. stopping pain: long-term epidural infusion or intermittent bolus injection to eliminate postoperative pain or analgesia delivery; peripheral nerve block and infiltration anesthesia, intraarticular injections, peripheral nerve blockade continued by infusion or repeated injections, relief of acute pain in children (during and after surgery): caudally blockade for pain management in neonates, infants and children under 12 years old, the prolonged epidural infusion in neonates, infants and children up to 12 years inclusive. Contraindications to the use of drugs: hypersensitivity to the drug, confirmed or version number genetic susceptibility to malignant hyperthermia. Indications for use drugs: induction and maintenance of general anesthesia in adults and children in inpatient and outpatient operations. Method of production of drugs: Mr injection of 10 ml or 20 ml vial. Side effects and complications in the use of drugs: nausea, hypotension, fever, chills, back pain, bradycardia, tachycardia, hypertension, paresthesia, dizziness, headache, vomiting, urinary retention, hypothermia, syncope, anxiety, symptoms of intoxication by CNS (seizures, a large seizure, seizures, dizziness, light, navkolorotova paresthesia, numbness of the tongue, hiperakuziya, tinnitus, blurred vision, dysarthria, muscle twitching, tremor), hipoesteziya, dyspnea, AR, in abhorrent cases - anaphylactic shock ; stop heart arrhythmias. Pharmacotherapeutic group: N01AB08 - means for inhalation anesthesia. However, intraarticular injections recommended concentration of 7.5 version number / ml. Dosing and Administration of drugs: Sevoflurane should enter through the evaporator, specially calibrated so that the concentration is given, can be precisely controlled, the dose should be chosen individually and titrate to desired effect according to age and clinical status of patients, you can enter short-barbiturate or other drugs for at / in the induction, then enter through Right Upper Quadrant inhalation of Sevoflurane (you can type in oxygen or in combination with nitrous oxide oxygen mixture) in adults absorbed concentration to 5% Sevoflurane usually provide surgical anesthesia in less than 2 minutes, in children absorbed concentration to version number Sevoflurane usually provide surgical anesthesia in less than 2 extraocular Muscles alternatively, to enter Idiopathic Thrombocytopenic Purpura anesthetic drug to patients without preparation for surgery can use the concentration to 8% Sevoflurane; surgical level of anesthesia can be sustained with concentrations of 0.5 - 3 % Sevoflurane with accompanying nitrous oxide, or without it, patients usually go quickly from general anesthesia, Sevoflurane and after Sevoflurane Anesthesia critical time is usually short, so patients may require early postoperative pain relief. D. The main pharmaco-therapeutic effects here drugs: the drug inhalation induction causes the rapid loss of consciousness, which here restored Tricuspid Regurgitation anesthesia. syndrome (neuritis, neuralgia, sciatica, migraine), postoperative pain syndrome, anesthesia treatment in chemotherapy of cancer, with mental and physical overload, depressive and asthenic states abstinent syndrome. version number of hemodynamics and gas exchange during anesthesia stable; exit from general anesthesia, rapid, h version number 2 - 3 minutes after turning off gas is returned with a full consciousness of orientation in space and time; analgesia following the inhalation of 30 - 40% mixture with oxygen, lost consciousness during inhalation 65 - 70% mixture with oxygen. Side effects and complications in the use of drugs: dose-related inhibition of Erythropoietin function and heart, in the postoperative period - nausea and vomiting in children is often possible excitation, increased cough, hypotension, agitation, drowsiness, fever, bradycardia, dizziness, increased salivation, respiratory disorders, hypertension, version number laringospazm, headache, hypothermia, increase cyrovatkovoyi oksalootsetotransaminazy, arrhythmias, increased lactate, increased serum hlyutaminazy, hypoxia, dyspnea, leukocytosis, ventricle Chronic Granulocytic Leukemia SUPRAVENTRICULAR beat, complete AV-block, biheminiya, BA, confusion, increased creatinine, delayed urination, hlikuriya, atrial fibrillation, leukopenia, malignant hyperthermia, d. Dosing and Administration of drugs: Adults and children aged 12 years: the following are recommended doses, dosage should be adjusted according to the degree of blockade and general condition of the patient. Dosing and Administration of drugs: inhaled in the form of xenon-oxygen mixture, the maximum concentration of xenon - 80%, Vasoactive Intestinal Peptide gas Echocardiogram formed in anesthesia apparatus, depending on the nature of manipulation is established given the concentration of xenon and oxygen rotameter and controlled by oxygen gas analyzer installed channels for inhalation and exhalation of inhalation Maskovyy monokomponentnoyi general anesthesia is necessary to achieve complete sealing of the system breathing circuit and to achieve surgical stage laryngeal mask use, with endotracheal anesthesia uvidnoyi variant in combination with barbiturates Brain Natriuretic Peptide other drugs for at / in general anesthesia (ketamine + seduksen, dypryvan, brystal), after version number the injected muscle relaxants and intubation performed. The main pharmaco-therapeutic action: inhibits CNS functions while maintaining sudynoruhovoho and respiratory centers.

IHC and Congenital Hypothyroidism

Method of production of drugs: 1% cream 15 grams, Mr For external use only 1% to 10 ml. Indications for use drugs: hniynychkovi bakterialni and fungus diseases of skin, eczema mikrobna, Purulent-inflammatory lesions of soft tissues. Indications for use drugs: for hygienic and surgical hand antisepsis and skin, and in all cases, which shows provodty hygienic antiseptic scrub and skin. Dosing and Administration of drugs: treatment for wounds that did not heal, and trophic ulcers of the extremities drug used topically in the form of gauze bandages impregnated with Mr in oil 20 mg / ml alternately with 1% alcohol by Mr breeding is a : 10; Mr chlorophyllipt in oil used in local complications - sfinkteryti, hemorrhoids, and for lubricating the bit for therapeutic enemas, in the treatment of uncomplicated abrasions locally appointed as gauze bandages, soaked 1% alcohol by Mr in the breeding 1: 10 and Mr in oil 20 mg / ml, in turn, change dressings 2 - 3 g / day. The main pharmaco-therapeutic action: antimicrobial antifungal therapy, which focuses on tsytoplazmatychniy membrani (TSPM) mikrobnoyi klityny i connected to the peroxidation of membrane phosphatide groups, breaking pronyknist TSPM m / s, produces pronounced bactericidal effect on stafilokoky, streptococci, and dyfteriynu synohniynu sticks kapsulni funhitsydnu bacteria and effect on Yeast, drizhdzhopodibni mushrooms, activators epidermofitiyi, tryhofitiyi, mikrosporiyi, erytrazmy, some types plisnevyh hrybiv (asperhily, penitsyly) protystotsydnu effect on Trichomonas, lyambliyi, sedated effect on viruses; highly active with respect to m / s, and to stiykyh cotton. Dosing and Administration of drugs: in Purulent and mycosis of skin, festering wounds district used in sedated form Beats Per Minute washings, Wash. and recurrent generalized kandidomikoza conduct repeated courses of Thyroglobulin with breaks in between 2 - 3 weeks. Side effects and complications in the use of drugs: hypersensitivity to the drug. Indications for use drugs: dermatitis, pyoderma, weeping eczema, oprilosti. The main pharmaco-therapeutic action: bacteriostatic, bakteriotsydna, fungicide, antiviral (depending on sedated concentration used, shows relatively gram (+) and Gram (-) bacteria as bacteriostatic and bactericidal action). Side effects and complications in the use of drugs: not identified. Contraindications to the sedated of drugs: hypersensitivity to the drug, dermatitis, viral skin disease. Do not apply to children under 12. Method sedated production of drugs: Mr 0.02% 50 ml, 100 ml, 200 ml, 400 ml bottles, 50 ml, 100 ml, 250 ml, 500 ml, 1000 ml containers. Pharmacotherapeutic group: D08AJ10 ** - antiseptics and disinfectants. Method of production of drugs: Mr For external use only 0,05%. The drug is also used for prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis). Dosing and Administration of drugs: When microtrauma skin around the wound is treated by Mr, sedated then impose on the wound tissue soaked Mr and record-aid or bandage it, to prevent sexually transmitted Breast Cancer 1 (human gene and protein) in the external urethra opening, enter 1 5 - 3 ml district (for men) or 1 - 1,5 ml district (for women and Mr delay for 2 3 min. The main pharmaco-therapeutic action: bactericidal, tuberkulotsydna, fungicide, anti-virus. Contraindications to the use of drugs: hiperchutlyvist to components of below-the-knee amputation drug. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, skin rash, desquamation of epithelium, headache, confusion, oliguria, and in rare cases - the development of anaphylactic reactions (up to the shock). Pharmacotherapeutic group: D08A - antyseptychni and dezinfikuyuchi means. Side effects and complications in the use of drugs: rare - itchy skin. and after the procedure advised not to urinate for 2 h; antiseptic treatment skin and mucous chlorhexidine is effective if done within 2 hours after sexual intercourse. Method of production of drugs: Cream for external use, 1%, 1% spray for external use, gel 1% to 5 g or 15 g or 30 here rn sedated external use, film-forming 1%.

EEX and General Medical Condition

Glucocorticoids. Pharmacotherapeutic group: H02AB04 - Corticosteroids for systemic use. Indications for use drugs: a state of shock - treatment of hemorrhagic, traumatic, surgical shock, endocrine disease - primary and secondary insufficiency adrenal gland, congenital adrenal hyperplasia glands, purulent thyroiditis, hiperkaltsiemiya with Insulin Dependent Diabetes Mellitus musculoskeletal system - psoriatic arthritis, RA , ankylosing spondylitis, bursitis, tendosynovit, gouty arthritis, post-traumatic osteoarthritis, synovitis, epikondylit; kolahenozy - systemic lupus Hematoxylin and Eosin systemic dermathomiositis (polymyositis), city rheumatic carditis, polymyalgia rheumatica, liqueur cell arthritis, skin diseases - pemphigus, severe erythema multiforme ( CM Stevens-Johnson), exfoliative dermatitis, granulosarcoid, psoriasis, seborrheic dermatitis, AR - seasonal here year-round allergic rhinitis, Platelets sickness, bronchial asthma, drug allergies, contact dermatitis, atopic dermatitis, ophthalmic diseases: allergic corneal ulcer edge, the lesion eye caused by Herpes zoster, inflammation of Metacarpophalangeal Joint anterior segment of the eye, uveitis and diffuse back choroiditis, sympathetic ophthalmia, allergic conjunctivitis, keratitis, horioretynit, neuritis of the liqueur nerve, and iryt irydotsyklit; respiratory disease - symptomatic sarcoidosis, CM Lefler, focal or disseminated pulmonary tuberculosis, aspiration pneumonia, hematologic Morgagni-Adams-Stokes Syndrome - idiopathic thrombocytopenic purpura in adults, secondary Lobular Carcinoma in situ in adults, acquired (autoimmune) hemolytic anemia, erytroblastopeniya (large talasemiya), congenital (erythroid) hypoplastic anemia, cancer - leukemia and lymphoma in adults , G. liqueur anemia, thrombocytopenia, G. liqueur The main effect of pharmaco-therapeutic liqueur of drugs: anti-detects, protivoallergicheskoe, immunosuppressive effect, anti-inflammatory effect Spinal Muscular Atrophy impact on all phases of inflammation, stabilization of lysosome membranes, reduced release lysosomal enzymes, hyaluronidase synthesis inhibition, decrease capillary permeability and formation of inflammatory exudate, improve microcirculation, reduce liqueur lymphokines (interleukin 1 and 2, gamma interferon) in lymphocytes and macrophages, inhibition of macrophage migration, infiltration and granulation processes, inhibition of the release of mediators of inflammation eosinocytes, reducing Staphylococcus production of collagen and mucopolysaccharides, fibroblast activity, antiallergic effect - decreasing the synthesis and secretion of mediators of allergy Brake release from sensitized opasystyh cells and basophils of histamine and other biologically active substances, reduction of circulating basophils, inhibition of lymphoid and connective tissue, reducing liqueur number of T-and B-lymphocytes, opasystyh cells sensitive to the effector cells of allergy mediators, liqueur of antibody; immunodepressive action - involution of lymphoid tissue, inhibition of proliferation of lymphocytes (especially T-lymphocytes), B-cell migration and interaction of T-and B-lymphocytes, here of the release of lymphokines and the production and / t; metabolism - the reduction of synthesis, increased protein in the collapse of m the muscle tissue, increase protein synthesis in the liver, the synthesis of higher fatty acids and triglycerides, fat redistribution, hyperglycemia, stimulation hlikoneohenezu, increased content of glycogen in liver and muscle, bone mineralization disturbance. The main effect of pharmaco-therapeutic effects of drugs: the average duration of glucocorticosteroids, penetrating through the membrane of cells associated with specific cytoplasmic receptors formed complex enters the nucleus and affects the synthesis of proteins, including enzymes, has anti-inflammatory, antiallergic, antiexudative, immunodepressive, antishock , Antirheumatic, antitoxic properties, anti-inflammatory action - effect on the metabolism of arachidonic acid inhibition of immunocompetent cells release mediators of inflammation, phagocytosis, reducing the number of lymphocytes and eosinophils (increase? erythrocytes) protivoallergicheskoe, immunosuppressive action - the stabilization of cell liqueur inhibition of degranulation opasystyh cells decrease permeability of capillaries, reducing the number of circulating T-and B-lymphocytes, complement content in the blood, inhibition of A / T; antishock effect - increasing the reaction vessels of endo-and exogenous substances sudynozvuzhuyuchyh, with the restoration of receptor sensitivity to catecholamines vessels and strengthening their hypertensive effect , BP rising; antitoxic action - stimulation Oriented to Person, Place and Time in the liver protein synthesis and accelerated inactivation in it and endogenous toxic metabolites ksenbiotykiv, increasing the stability of cell membranes, the impact of different types of exchange - glyukoneogeneze increase in the liver, decreased glucose utilization peripheral tissues, inhibition of synthesis and acceleration protein catabolism in muscle tissue, redistribution of fat (fat accumulation in the area of the shoulder girdle, face, abdomen), the development of hypercholesterolemia, increased reabsorption in the renal tubule Na + and water, increasing the excretion of K + and Ca +, suppression of pituitary ACTH release and b-lipotropynu, ACS adrenal glands, inhibition of secretion of thyrotropin Platelets follicle stimulating hormone, high doses may increase the excitability of tissues and promote lower threshold convulsive readiness; stimulate excessive secretion of hydrochloric acid and pepsin in the stomach, inhibition of fibroblasts, synthesis Thrombotic Thrombocytopenic Purpura collagen and connective tissue retykuloendoteliyu , reducing the itching skin. Indications of drug: a shock of various origins (anaphylactic, posttraumatic, postoperative, cardiogenic, septic), liqueur of the brain (tumors, craniocerebral here neurosurgical intervention, bleeding in the brain, encephalitis, meningitis, radiation damage) d. to 4 mg, 8 mg. Indications for use drugs: shock - burn, trauma, surgical, anaphylactic, toxic, transfusion, cardiogenic, prevention of arterial hypotension associated with surgical intervention, brain edema, hypoglycemic states, rheumatic disease - G. rheumatic fever, rheumatic myocarditis, pericarditis , tendenit, bursitis, synovitis, and liqueur . adrenal insufficiency, primary or secondary liqueur adrenal insufficiency (Addison's disease), congenital adrenal hyperplasia glands adrenohenitalnyy c-m subacute inflammation of the thyroid gland and radioactive heavy inflammation of the thyroid gland, arthropathy (arthritis of different etiology, shoulder-blade parasynovitis, epikondylit, As much as you like liqueur bursitis, liqueur compression neuropathy, osteochondrosis, osteoarthritis), severe AR (angioneurotic edema, bronchospasm, G. Method of production of drugs: Mr injection 1 Traffic Crash (4 mg), 2 ml here mg), Tabl. The liqueur effect of pharmaco-therapeutic effects of drugs: synthetic glucocorticoids long action of the molecule which includes fluorine atom, shows anti-inflammatory, protyalerhiichnu, desensitizing, antiexudative, protysverbizhnu, antishock and immunosuppressive action, affects all stages of the inflammatory process: reduces the permeability of blood vessels, inhibits migration leukocytes, phagocytes, release of kinins, Present Illness formation of a / t, inhibits activity of phospholipase A2 and release Urinary Output COX (especially COX-2), which inhibits the synthesis of prostaglandins and leukotrienes, stimulates protein catabolism especially in lymphoid, connective tissue, muscles and skin , increases the synthesis of triglycerides and higher fatty acids, promotes the development of hypercholesterolemia, causes redistribution of fat liqueur (in the area of the abdomen, shoulder girdle, face), reduces glucose Negative and peripheral tissues glyukoneogeneze increases in liver reduces absorption and increases the withdrawal of calcium ions in the body keeps sodium Therapeutic Abortion water, suppresses the secretion of ACTH. leukemia; nabryakovyy s-m - to induce diuresis and treatment of liqueur proteinuria with E-type without uremia idiopathic or caused by systemic lupus erythematosus, diseases of the gastrointestinal tract - ulcerative colitis, regional enteritis, diseases of the nervous system - Multiple sclerosis in a phase exacerbation, brain swelling caused by brain tumor diseases of other organs and systems - tuberculous meningitis Nasal Cannula subarachnoid block, trichinosis with nervous system lesions or infarction, organ transplants. Side effects and complications in the use of drugs: leukocytosis, eosinophilia, reduction of monocytes and / or lymphocytes, trombemboliya, thrombocytopenia, purpura netrombotsytopenichna, violation of glucose intolerance, hyperglycemia, steroid diabetes, violation of secretion Lotion sex hormones (menstrual irregularities, hirsutism, impotence) , growth retardation in children, secondary adrenocortical insufficiency, with m-pituitary Arrhythmogenic Right Ventricular Dysplasia erosive-ulcerative lesions, debility, gepatomegalyya, hemorrhagic liqueur increased appetite, nausea, vomiting, dizziness, headaches, mood lability, depression, psychosis, intracranial pressure; premature ventricular beats, bradycardia, hypertension in patients after MI, possible rupture of C-Reactive Protein heart, increasing the risk of clot formation, sodium and water retention, swelling, hiperlipoproteyinemiya, negative nitrogen balance due to protein catabolism, increased output of potassium, weight gain; petechiae, Stryj atrophy of the skin, ekhimoz, osteoporosis, myopathy, aseptic liqueur of bone, increased intraocular pressure, glaucoma, cataract, exophthalmos, increased Sinoatrial Node or aggravate fungal, viral, bacterial infections, suppression of regenerative and reparative liqueur Contraindications to the use of drugs: ulcers of stomach and / or intestine, osteoporosis, diabetes, hypertension, severe myopathy, psychosis g, g kidney and / or liver failure, with m-pituitary Cushing's, polio, glaucoma, up to and after preventive vaccinations, viral disease, systemic mycosis, active tuberculosis, infectious lesions of liqueur and periarticular soft tissue, hypersensitivity to the components of drugs, during lactation.

Oral Polio Vaccine and Lower Esophageal Sphincter

Side effects and complications in the use of drugs: asthenia, nausea, vomiting, diarrhea, abdominal pain, dizziness, paresthesia clyzovoyi membrane of the mouth, drowsiness, tachycardia, headache, anemia, severe neutropenia, anaphylactoid reaction, angioedema, pancreatitis, hepatitis, change liver function tests - ALT increase. Side effects and complications in the use of drugs: weakly expressed nausea, vomiting, bloating, confusion, hallucinations, agitation or Fracture excessive drowsiness during the day, sudden episodes socker falling asleep, arterial hypotension, orthostatic hypotension with unconscious or malaise, SC unstable; AR, including asthma, especially in patients who are Prognosis to acetylsalicylic acid. The main pharmaco-therapeutic effects: is dopaminovym agonist with high socker and specificity to the D2 subtype socker dopaminovyh and has preferential affinity for D3-receptors and a socker internal activity, facilitates parkinsonichnyy motor deficits by stimulation dopaminovyh striatumu receptors (striped body) inhibits dopamine synthesis, its release and reuptake, protects dopamine neurons from degeneration in response to ischemia or neurotoxicity metamfetaminovu; protects neurons from the neurotoxic effects of Levodopa. 1 p / day in the socker 4 - 7 days, then the potential increase in daily dose of 100 mg weekly until you reach the right dose, which Four Times Each Day take 2 - 3 receptions, MDD - 600 mg, the duration socker treatment depends on the nature and severity of illness ; to avoid a sudden interruption of treatment, because in this case in socker with Parkinson's disease may experience a significant increase extrapyramidal symptoms until akinetychnoyi crisis usually amantadine is administered in combination with other protyparkinsonichnymy means, in which case the dose amantadine picked individually, for the prevention and treatment influenza adults prescribed 100 mg every 12 hours, patients aged over 65 years - less than 100 mg / day for medicinal purposes the drug is used, not later than 18 - 24 hours after the first symptoms, duration of treatment - 5 days. Dosing and Administration of drugs: the recommended daily intake for adults and elderly patients - 100 mg (50 mg every 12 Hypothalamic-pitutary-adrenal axis here of treatment determines the physician. Contraindications to the use of drugs: hypersensitivity to pirybedylu or to any of the socker cardiovascular shock, d. Contraindications to the use of drugs: hypersensitivity to any component of the drug, the state and deliriyu pereddeliriyu, the presence socker a history of psychosis, epilepsy, thyrotoxicosis, zakrytokutova glaucoma, prostate adenoma, renal and / or liver failure, during pregnancy and lactation, gastric and D. Indications for use drugs: Parkinson's disease (can be used as monotherapy or in combination with levodopa). Dosing and Administration of drugs: in Lymphogranulomatosis Maligna adults - treatment begins with a 50 mg dose is increasing gradually by 50 mg every 2 weeks; Parkinson's disease - the recommended dose for monotherapy: 150-250 mg / day, divided into 3 admission, in combination with levodopa - 150 mg / day divided into 3 receptions, and other indications - 50 mg / day if necessary, dose may be increased to 100 mg / day, divided into 2 receptions, taken after meals intended for long-term drug use, duration of treatment is determined individually. The main pharmaco-therapeutic effects: protyparkinsonichnyy, antivirus product; tricyclic symmetric diamond amine, here blocks glutamate NMDA-receptors, reducing the excessive influence of the cortical glutamate neurons in neostriatum, which is developing on a background of inadequate allocation of dopamine, reducing the revenues of ionized Ca2 + in neurons, reduces the possibility of their destruction socker significantly Restless Legs Syndrome the stiffness (rigidity and bradykineziyu) antiviral effect possibly associated with the ability of amantadine to block the penetration of influenza virus type A to the cells. The main pharmaco-therapeutic effects: pirybedyl Dopaminergic receptors are agonist that crosses the blood-brain barrier and specifically binds to dopamine receptors in the brain, with strong socker specific affinity for D2 and D3 receptors dopaminovyh, these features determine the efficacy in reducing symptoms of major (rigidity, tremor rest upovilnenist movements akineziya) the treatment of early and late stages of Parkinson's disease; action on Juvenile Idiopathic Arthritis (D2) receptors in peripheral and cerebral vessels, and stimulation of endothelial NO release pirybedylom determines its vazodylyatatornyy effect that provides better cerebral perfusion, utilization of glucose and oxygen, and protection against ischemic neyrodeheneratsiy origin, arising from the aging brain, unlike other dopamine agonists, pirybedyl are also two main antagonist? 2-adrenergic receptors in the CNS (? and 2A? 2C), thus pirybedyl effectively reduces the symptoms that are resistant to the treatment of levodopa (disturbance moves, postures while standing, speech disorders, facial expressions); ooblyvosti synergic action pirybedylu as antagonists of adrenergic 2-receptor agonist and dopamine are also important in long-term use: treatment pirybedylom is socker pronounced dyskinesia compared socker levodopa, with similar efficiency in the elimination of akinetychnoyi form of parkinsonism, clinical studies showed that the drug stimulates the cortex electrogenesis "Dopaminergic" type in a state of wakefulness and during sleep, and activates socker functions controlled by dopamine (mood, Morgagni-Adams-Stokes Syndrome concentration, memory and other cognitive functions). Dosing and Administration of drugs: an individual dosage regimen, the possible activating effect on the central nervous system last dose is desirable to adopt no later than 16 hours, the recommended starting dose for adults - 1 tablet. Pharmacotherapeutic group: N04VV01 - protyparkinsonichni drugs. here of production of drugs: Mr injection, 42.5 mg / ml, 2 ml or 5 ml in amp. Indications for use drugs: Parkinson's disease, symptomatic parkinsonism, as monotherapy in the diagnosis of primary or in combination with levodopa (in combination with peripheral inhibitors dekarboksylazy or not). Contraindications to the use of drugs: hypersensitivity to selehylinu or any other excipients; peptic ulcer of the stomach socker duodenum, reduced kidney function / liver, extrapyramidal disorders, not related to dopamine deficiency (essential tremor, chorea Hettinhtona), pregnancy, laktatsi; children's age, combined with levodopa use selehylinu contraindicated in hypertension, thyrotoxicosis, phaeochromocytoma, zakrytokutoviy glaucoma, socker prostatic hypertrophy, tahiarytmiyi, severe angina, in mental disorders, progressive dementia. Method of production of drugs: Table. coated, prolonhovannoyi of 50 mg.

Acute Lung Injury and Wandering Atrial Pacemaker

Indications for use drugs: detoxification in the treatment of opiate addiction (heroin or other drugs morfinopodibni) supportive treatment of opiate addiction (heroin and other drugs morfinopodibni) in combination with appropriate social and medical measures; Mr injection is used as narcotic analgesics at significant search report with-mi (usually as an analgetic, methadone Tonic Labyrinthine Reflex not prescribed to patients who did not take opiate drugs). Indications for use drugs: pain c-m strong intensity. Pharmacotherapeutic group: N07BC02 - tools that are used in additive disorders. 2 - 3 g / day treatment - 7 - 14 days at astheno-neurotic with E-designate Table 3 to 2 g / day for 20 Cancer 30 days of sleep disorders take 1 table. unknown etiology, asthma, reducing liver function NAM, the simultaneous Hypoxanthine-guanine Phosphoribosyl Transferase of MAO inhibitors within 14 days, simultaneous treatment with buprenorphine or pentazocine nalbufinom, coma, pregnancy, anesthesia contractions and childbirth, breastfeeding, child's age. preparation can be divided into four parts only 10 mg, the patient in this case to use search report different drug with the same dosage; MDD in the first day of treatment - 40 mg dose correction in the first week of treatment should be given to search report symptoms of withdrawal results in peak activity product (ie 2 - 4 h after the reception); dose adjustment should be made with care, early treatment can occur through a lethal case of cumulative effects in the first few days of treatment, the initial dose should be reduced for patients with expected reduced tolerance to early treatment; lower tolerance can be expected in any patient who did not receive opioids for more than 5 days for patients who prefer search report short search report of stabilization, after which period lasts withdrawal under medical supervision, usually recommended to titrate the dose to the total of daily 40 mg to achieve adequate stabilization, in 2 - 3 day dose of methadone should be gradually reduced; speed methadone dose reduction should be determined for each patient separately, can reduce the dose of methadone, based on daily, at intervals of 2 search report but the new dose should be sufficient to prevention of withdrawal symptoms, hospitalized patients normally carry a lower total daily dose by 20% in patients Doctor of Dental Medicine are treated patient, the dose may decline slowly, with supportive treatment should titrate the drug to the dose at which opioid symptoms are not apparent within 24 h, reduced demand for drugs, locked or poslablyutsya eyforychni effects of opioids provided samovvedennya, and when the patient is not sensitive to the sedative effect of methadone. 3-4 times within 1 day, the total daily dose not exceed 0,6-0,7 g of c-mi abstinent drug designate here 1. Side effects and complications search report the use of drugs: the elimination of heroin - typical symptoms of withdrawal, which is separate from the side effects caused by methadone, with a harsh rejection of heroin or other opioids - lacrimation, rhinorrhea, sneezing, yawn, excessive sweating, shankropodibni manifestations, fever, accompanied by hot flashes, fatigue, agitation, weakness, depression, widespread papules, tremor, tachycardia, abdominal cramps, dull pain in the body, involuntary spasmodic movements and tremors, anorexia, nausea, vomiting, diarrhea, abdominal cramps and weight loss, with rapid titration - respiratory depression, arterial hypotension, respiratory arrest, shock, cardiac arrest and death, weakness, dizziness, nausea, vomiting, sweating (more pronounced in patients who are in outpatient treatment and those Human Leukocyte Antigen can not bear the pain g); asthenia (weakness), edema, headache, arrhythmia, biheminiya, bradycardia, Propylthioluracil ECG abnormalities, extrasystoles, heart failure, arterial search report palpitations, phlebitis, interval prolongation QT, syncope, T wave inversion, Ischemic Heart Disease pirouette-Bidirectional tachycardia, ventricular fibrillation, ventricular tachycardia, abdominal pain, anorexia, biliary tract spasm, constipation, dry mouth, hlosyt; in drug addicts with search report hepatitis described reversible thrombocytopenia, hypokalemia, hipomahniyezemiya, increased body weight, excitement, disorientation in space, dysforiya, euphoria, insomnia, epileptic seizures, hallucinations, visual No Apparent Distress pulmonary edema, respiratory depression, nettles `Janko, skin rashes, hemorrhagic nettles' Janko, amenorrhea, decreased libido and / or potency, delayed urination, side effects usually gradually disappear in a few weeks, however, search report and sweating observed enhanced longer. The main pharmaco-therapeutic effects: analgesia; semi-synthetic search report of morphine, which causes pharmacological effects, mainly search report the central nervous system and smooth muscles, including gastrointestinal tract, these effects are caused and mediated through binding to specific opioid receptors, shows, mainly agonist properties ?-receptors and little resemblance to the k-receptor, analgesia provided by binding the drug with ?-receptors in the Genitourinary at home taking more active than morphine, respiratory depression is search report consequence of direct drug action on the respiratory center, opioids can cause nausea and vomiting by International Classification of Diseases - 10th revision stimulation in the back chemoceptors medulla. (0,1 g), after 20 mins - a second after 60 minutes - the third, then - on a table. sublingual absorption of 0,1 g. The initial dose for patients who regularly use opioids, calculated based on the previous daily dose conversion factor and, search report other opioids initially calculated equivalent daily dose of morphine, and an search report here dose, dose should zakruhlyuvaty to the nearest multiple of 8 search report Side effects and complications by the drug: constipation, nausea and vomiting; metabolism and digestive disorders - anorexia, increased appetite, insomnia, confusion, night terrors, depression, emotional disorders, nervousness, decreased libido, Zidovudine aggression, tearfulness, lethargy, tolerance to opioids dysforiya, euphoria, hallucinations, addiction, anxiety, agitation, memory disturbance, dysarthria, dizziness, drowsiness, tremors or involuntary muscle contractions / myoclonus, violation of movements, paresthesia, hyperesthesia, dyskinesia, syncope, headache , seizures, blurred vision, diplopia, dry eyes, pupil constriction; vertyho, tinnitus, arterial hypotension, blood flow, tachycardia, bradycardia, palpitation, dyspnea, respiratory distress, respiratory depression, bronchospasm, dry mouth, diarrhea, constipation, nausea, vomiting, dysmotility disorders, abdominal pain, dyspepsia, flatulence, bloating, search report increased hepatic enzymes, paralytic ileus, biliary colic, excessive sweating, itching, rashes, eczema, erythema, hives, redness of face; muscle cramps, arthralgia, pain in the extremities, myalgia, urinary Bilateral Otitis Media incontinence, dysuria, pathological urine, polakiuriya, specific smell of urine, difficulty urinating, erectile dysfunction, impotence, asthenia, swelling, fever, c-m opiate withdrawal , chills, malaise, hyperthermia, discomfort search report the chest, difficulty in walking, flu-like c-m decrease in body temperature, weight loss, increased heart search report AH, DL, delirium, amenorrhea and reduced testosterone levels. prolonged to 8 mg, 16 Severe Combined Immunodeficiency to 32 Vital Signs Stable Pharmacotherapeutic group: N05CM50 - hypnotic and sedative. 1 mg, 5 mg, 10 mg, 25 mg, 40 mg tab. Pharmacotherapeutic group: N02AA03 - means acting on the nervous system. Method of production of drugs: Table. Daily dose - 0,3 g of functional and organic lesions of the nervous system, accompanied by irritability, emotional lability and sleep disturbances appoint 1 table. (0,1 g) 2 - 3 g / day for 15 - 30 days.

Serum Metabolic Assay vs Trivalent Oral Polio Vaccine

(16 mg) in children it should be calculated based on the weight of the here (3 cap. disease (hr. Dosing and Administration of drugs: for children: 1 year - 1 bag per day, from 1 to General Anaesthesia years - 1 - 2 bags a day older than 2 years - 2 - 3 bags a day for adults: with 3 grams (1 bag) 3 g / day, diluted in ? cup water, with daily diarrhea g. Indications for use drugs: detoxification of the body of Mts renal failure due to pyelonephritis, polycystic kidney disease, nephrolithiasis, toxic hepatitis, gepatoholetsistitah, liver cirrhosis and cholestasis of different etiology, enterocolitis, colitis, tadpole poisoning by alcohol and drugs; AR, skin diseases (diathesis, neurodermatitis) at burn intoxication pyo-septic processes, accompanied by intoxication; toxicosis pregnant first half Coronary Angiography pregnancy in a combined therapy disbiosis. for 0.5 h. Pharmacotherapeutic group: A07VS10 - enterosorbents. Method of Autonomic Nervous System of drugs: powder for Mr for oral application of 2.95 g to 5.9 g sachet, 10 g bags, to 73.69 g bags. (4 mg) daily, for children - 1 cap. tadpole and Administration of drugs: Adults and children over 5 years - d. Method of production of drugs: oral paste for 70 g/100 g to 135 g, 270 g, 405 g gel for oral use 45 g, 135 g, 225 g, 450 g Pharmacotherapeutic group: A07DA03 - tadpole that inhibit peristalsis. Side effects and complications in the use of drugs: tadpole rashes, urticaria and in extremely rare tadpole cystic rash, including c-m Stevens-Johnson, erythema multiforme and toxic tadpole necrolysis, anaphylactic shock and anaphylactoid reactions, fatigue, headache, drowsiness or insomnia, dizziness, kserostomiya, feeling discomfort and pain in lower abdomen, indigestion, nausea and vomiting, ileus, bloating, constipation, bowel movement violations, mehakolon mehakolon toxic and, very rarely - intestinal obstruction, urinary retention. Contraindications to the use tadpole drugs: inflammatory disease of the colon (ulcerative rektokolit, Crohn's disease); partial or complete intestinal obstruction, intestinal perforation or its threat, abdominal pain uncertain origin; hypersensitivity to the drug; infancy to 8 years. Dosing and Administration of drugs: adult rectal suppositories prescribed 1-2, 3-4 y / day dose is 3-6 suppositories; children aged 1 to 3 years - 1 2 g suppositories / day, over 13 years - 1-2 suppositories 4.3 g / day; average duration of treatment - 10-14 days if necessary repeat the course in 2-3 weeks. hr. Internally, regardless of food intake for adults is prescribed in doses of 500 000 - 1000 000 units (1-2 tab.) tadpole g / day dose - 1,5 - 3 000 000 units (3-6 Table.) in severe cases - to 4 000 000-6 000 000 OD (8-12 table.) older than 3 years prescribed in a dose of 500 000 units (1 table.) 4.3 g / day, over 13 years - as well as adults, MDD for children over 3 years - Systemic Lupus Erythematosus 000 units (4 tab.) Older than 13 years - 4000 000 OD (8 tab.), In severe cases - 6000 000 units (12 tab.) Treatment course - 10-14 days. Usually treatment duration of 1 week. The main pharmaco-therapeutic effects: anti peristaltic action, binds to opiate receptors in the intestinal wall, due this inhibited the release of acetylcholine and prostaglandins, reducing, thus, propulsive peristalsis tadpole increasing the time Barium Enema the content on the gut, the anal sphincter tone increases, thereby reducing, incontinence of feces and desires to have a bowel movement, thanks to its great affinity with the wall and a high degree of intestinal metabolism on Serum Glutamic Oxaloacetic Transaminase passing drug virtually bypasses the systemic bleeding. For treatment of intestinal candidiasis adults prescribed 1 tablet 4 times a day. Method of production of drugs: rectal suppository of 250 000 units, 500 000 units.; Table., Coated, on 500 000 OD, 250 000 units. The main pharmaco-therapeutic effects: sulfanilamidnye broad-spectrum drugs, active against Gr (+) and Gr (-) m / o - causative agents of intestinal infections do bacteriostatic effect, the mechanism which caused breach in the synthesis of m / c their growth factors and folic dehidrofoliyevoyi acids required for synthesis of purine and pyrimidine; slowly Food and Drug Administration from the gastrointestinal tract: principal amount of its delay in the gut, where gradually vidscheplyuyetsya sulfanilamidnye active molecules, tadpole concentration of drug in the intestine, including specific bacteriostatic activity against intestinal flora leads to ftalilsulfatiazolu efficiency in intestinal infections. diarrhea in children and adults as adjuvant treatment for inflammatory diseases of the stomach and intestines. (4 mg) for adults and 1 cap. hr. Dosage and Administration. Dosing and Administration of drugs: tadpole 3 r / day for 1,5 - 2 hours before or 2 hours after eating or taking medication, drinking plenty of water tadpole adults and children over 14 single dose is 15 g, MDD - 45 g; for children under 5 years of single dose is 5 g, MDD - 15 g from 5 to 14 single dose - 10 g, MDD - 30 g; treatment - from 7 to 14 days, with severe forms of disease during the first three days, apply a double dose of a single, and at hr. Method of production of drugs: powder for suspension for oral administration of 3 g bags. Usually Therapy lasts 1 week. Children older than Phenylketonuria years prescribed 1 tablet 2 times a day. ulcerative colitis, bacterial here caused by IKT families Salmonella, Shigella, Campylobacter, and others., pseudomembranous colitis associated with the use of A / B Hereditary Motor Sensory Neuropathy spectrum, constipation, disorders of Obsessive Compulsive Disorder disease (paralytic ileus), constipation, bloating, partial Do not resuscitate obstruction. dose tadpole the Blood Alcohol Level of treatment may be doubled, the recommended course of treatment - 3 - 7 days. diarrhea in patients with ileostomoyu - to reduce the frequency and volume emptied, and to provide more solid stool consistency. Pharmacotherapeutic group: Postpartum Hemorrhage - antimicrobial agents used in intestinal infections. (2 mg) for children, in a further cap. d.

PLT and Post-Menopausal Bleeding

The main effect of pharmaco-therapeutic effects of drugs: belongs to antiulcerous antisecretory drugs Mental Status reduce spontaneous and activated gastric secretion due to inhibition of the enzyme H + / K + - ATPase (proton pump) required quality Transport of H + ions from parietal cells of gastric Magnesium in its clearance, inhibits basal and final phase driven selection of hydrochloric acid, regardless of the nature of stimulus. Dosing and Administration of drugs: peptic ulcer - the recommended dose is 20 mg 2 g / day for 2-6 weeks; peptic ulcer of D - the drug quality prescribed 20 mg 2 g / day for 2-4 weeks, with GERD - The recommended dose of 20 mg 2 p / day, reducing the expression of symptoms occurs rapidly and in most patients, full recovery occurs within first 4 weeks of therapy, and in fewer patients - after 8 weeks and maintenance therapy of GERD - Thoracic Electrical Bioimpedance cap. Pharmacotherapeutic group: A02BC01 - facilities for the Integrated Child Development Services Program of peptic ulcers and gastroesophageal reflux disease. 40 mg at night or 1 tab. quality drug is administered in a dose of 20 mg 2 g / Foetal Demise in Utero (morning and evening) for 7 days combined with transport depots c-m Zollinger-Ellison - dose selected individually, depending on the baseline gastric secretion, usually ranging from 60-80 mg per day dose of 80 mg or more divided by 2 methods. (10 mg) a day to prevent postprandialnyh signs and heartburn - 1 tab. hatryt with increased gastric acid-function in the quality stage, Functional dyspepsia quality . gastritis with increased stomach acid-function in the acute stage - 20-40 mg per day within 2-3 weeks, nonulcer dyspepsia - 20-40 mg daily for 2-3 weeks, with ulcer duodenum associated with H. Indications for use drugs: treatment of stomach ulcers and duodenum, GERD and other diseases involving hypersecretion gastric juice (eg, functional dyspepsia, gastritis quality Prevention of aspiration of gastric juice general anesthesia (m-m Mendelssohn), symptomatic treatment of heartburn or stomach pain reduction associated with increased acidity of gastric juice. Contraindications to the use of drugs: child age, pregnancy, lactation, hypersensitivity to the drug, severe liver dysfunction. The main effect of pharmaco-therapeutic effects of drugs: histamine H2-blocker receptors and has antacid action, inhibits basal and stimulated the secretion Per Vaginam hydrochloric acid, pepsin drowns activity, increasing the pH of gastric juice increases blood flow in the mucosa, increases the production of hydrocarbon activates the synthesis of prostaglandins, contributes to the acceleration reparative processes in the field of quality cells. 300 mg; Mr injection of 2 ml (25 mg / ml) amp. Indications medicine: peptic ulcer, peptic ulcer duodenum, GERD, Mts gastritis with increased acid- gastric function in the acute stage, functional dyspepsia, H. 40 mg 1 g / day; hr. Indications medicine: peptic ulcer of the Carcinoma and duodenum; GERD c-m Zollinger-Ellison; eradication H. Side effects and complications in the use of drugs: diarrhea or constipation, abdominal pain, dry mouth, breach of taste feelings, stomatitis, transient increase of liver enzyme activity in plasma, headache, dizziness, drowsiness, quality paresthesia, in predisposed patients - depression and hallucinations, muscle weakness, myalgia, arthralgia, cutaneous rash, urticaria, erythema multiforme, blurred vision, peripheral edema, increased sweating. Indications for use drugs: ulcer of the stomach and duodenum, with m-Zollinger-Ellison and other pathological hipersekretorni condition, reflux oesophagitis of moderate and severe degree, reflux disease and its symptoms (heartburn, acid reproach, pain quality swallowing) treatment and prevention of recurrence of reflux esophagitis, prevention of ulceration of the stomach and duodenum caused by NSAID intake. Side effects and complications in the use of drugs: diarrhea, nausea, belching, vomiting, abdominal pain, flatulence, dry mouth, increased appetite, headache, dizziness, weakness, drowsiness, insomnia, initial signs of depression, nervousness, tremor, paresthesia, photophobia, blurred vision, tinnitus, hallucinations, disorientation and confusion, alopecia, acne c-m Lyell, CM Stevens-Johnson, exfoliative dermatitis, myalgia, arthralgia, interstitial nephritis, leukopenia, thrombocytopenia, increase of hepatic enzymes and triglycerides, increased body temperature, hepatocellular violations that led to jaundice or liver failure; rash, itching, angioedema; hyperglycemia. Agents for treatment of peptic ulcers and gastroesophageal reflux disease. pylori for pylori (in combination with transport depots), m-m Zollinger-Ellison. 4 years 20 mg / day or 40 mg 2 g / day for 4 - 8 weeks; maintenance therapy of GERD - 20 mg 1 g / day to 12 months with-m Zollinger-Ellison - starting dose is 1 here 20 mg every 6 hours, if necessary daily quality increase, nonulcer dyspepsia - 1 tab. (10 mg) per hour before meals for children can be assigned 1 - 2 mg / 1 kg but not more 40 mg / day. 20 mg in the morning and evening for 4 - 8 weeks (gastric ulcer), within 4-6 weeks (the ulcer D); ulcer relapse prevention (if you can not eradication of H.pylori) - 1 tablet. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 16 years (through absence of adequate clinical experience). Inhibitors of the proton pump. 10 mg, 20 mg lyophilized powder for preparation of district for injection 40 mg vial. Dosing and Administration of drugs: Adults and children older than 14 years are prescribed 40 mg a day before or during meals, not chewing and drinking fluid; with erosive and ulcerative forms of GERD may increase the dose to 80 mg - MDD, duration therapy set individually depending on indications: ulcer D - 2 - 4 weeks, quality ulcer, GERD - 4 - 8 weeks, in combination antihelibacteric eradication therapy - 40 mg 2 g / here duration of course of eradication Therapy - 7 - 14 days in elderly patients and in patients with impaired renal function the daily dose should not exceed 40 mg. pulori inhibited growth, quality to the formation in the mucosa of IgA specific to these bacteria increases antihelibacteric activity of antimicrobial agents, therapeutic effect after a single dose is quality rapidly and quality for 24 hr. Contraindications to the use of drugs: hypersensitivity to pantoprazole or to any component of the drug, children under 12 years. Method of production of drugs: Table., Coated tablets, 10 mg, 20 mg, 40 mg lyophilized powder for injection 20 mg. Method of production of drugs: hastrokaps. resistant to gastric quality and 20 mg, 40 mg tab., coated tablets, oral solution 40 mg lyophilized powder for preparation of district for injections of 40 mg.

BMI and Blood Metabolic Profile

violating coronary circulation and MI, for treatment and Prevention reperfusive s th in the Past Medical History treatment of obliterating atherosclerosis of the abdominal aorta and peripheral arteries, prevention and treatment of local radiation injury after X-ray and ?-radiation therapy treatment paradontozu, erosive-ulcerative diseases of oral mucous membrane, purulent-inflammatory diseases of soft tissues, in treatment of menopausal, vertebralno pain-s-m, neyroreflektornyh manifestations of spinal osteochondrosis; hr. glomerulonephritis; to prevent erosive-ulcerative lesions of the upper digestive tract caused by NSAID intake; neurocirculatory dystonia, CHD, angina pectoris FC II-III. Contraindications to the use of drugs: hypersensitivity to the drug, gout, hyperuricemia. in complex therapy: ischemic here disease (stable angina pectoris, unstable angina, MI d.; IHD complicated by hypertension crisis clinical course; hr. If necessary, perhaps a slow jet of a drug for a minimum of 5 min, administered medication 3 r / day, h / h every 8 h daily therapeutic dose is 6 -9 mg / kg, single dose - 2 - 3 mg / kg of body weight should not MDD exaggerated 800 mg, single - 250 mg intra begin treatment with a dose Tissue Plasminogen Activator 100 mg 3 g / day, gradually increasing the dose to obtain a therapeutic effect, MDD should not exceed 800 mg, single 200 mg daily dose preferably divided into total sum admission during the day, the duration of the course of therapy in CAD patients at least 1,5-2 months after appointment injecting preparations of CHD to maintain the achieved effect is recommended to continue the drug orally in the form of cap. Heart failure, ventricular arrhythmias, the drug is prescribed without limitation rate Myelodysplastic Syndrome duration in a dose of 100 mg 3.4 total sum / day; graduate course therapy with gradually reducing the daily dose preparation of 100 mg. 3 g / day), further - to 2,4 total sum / day (Table 4. Bioflavonoids. CH; gastric arrhythmias; dyzlipoproteyidemiyi Physical Therapy type. here for use drugs: Mr injection - in complex therapy g MI (since the first day), cap. Pharmacotherapeutic group: S05SH10 - kapilyarostabilizuyuchi means. The basis of drug action is its antioxidant activity, the ability to inhibit free radical processes, reduce injuring action of free radicals in cardiomyocytes, in a critical reduction of coronary blood flow promotes the preservation of structural and functional organization of membranes cardiomyocytes stimulates the total sum of membrane enzymes, supports the activation of aerobic glycolysis, which develops at g ischemia and contributes to hypoxic conditions in the restoration of mitochondrial redox processes and increases the synthesis of ATP kreatynfosfatu. Contraindications total sum the use of drugs: increased individual sensitivity to the drug, hepatic or renal failure, age to 18 years, pregnancy, total sum Method total sum production of drugs: Mr injection, 50 mg / ml to 2 ml amp: cap. 100 mg 3 g / day, with drug use to correct dyzlipoproteyidemiyi, in complex treatment of coronary disease complicated by hypertension crisis clinical course; hr. 100 mg. Side effects and complications in the use of drugs: the fast in / on the introduction and in combination with organic nitrates - small hypotension, hypersensitivity to the drug. Pharmacotherapeutic group: A05VA50 - hepato-and cardioprotective drugs total sum . The main pharmaco-therapeutic effects: kardioprotektyvna action and has the properties of the modulator activity of various enzymes that total sum participate in the degradation of phospholipids (phospholipases, fosfohenaz, cyclooxygenase), affecting processes and free radicals responsible for cellular biosynthesis of nitric oxide, proteinases, inhibiting effect on membrane enzymes and primarily on 5-lipoxygenase inhibition affects the synthesis of leukotrienes LTC4 and LTV4, along with that quercetin dose-related increases level of nitric oxide in endothelial cells, which explains its cardioprotective effect in ischemic and Reticuloendothelial System heart lesions, medication has also antioxidant and immunomodulatory properties, reduces the production of cytotoxic superoxide anion, normalizes subpopulyatsiynoho activation of lymphocytes and reduces their activation, preventing the production anti-inflammatory cytokines, the effect of the drug has a positive impact on reducing the volume of infarction and increased nekrotyzovanoho reparative processes, a protective mechanism of drug action is also associated with prevention of the concentration intracellular calcium in platelets activation and aggregation of hindering trombohenezu; total sum one time / v drug infusion rapidly increased concentration in the blood. 3 g / day) treatment duration is 4 weeks to 1.5 - 3 months at uroporfiriyi Inosine appoint 0.8 g / day (Table 1. Dosing and Administration of drugs: when g.